Sarepta Therapeutics Inc. (NASDAQ: SRPT) had its price target boosted by equities researchers at Wedbush from $0.00 to $66.00. The company currently has a rating of Outperform on the stock. The one-year price target of $44.46 is a decrease compared …

Sarepta Therapeutics Inc. (NASDAQ: SRPT) had its price target raised by equities researchers at Needham & Company LLC from $47.00 to $60.00.Needham & Company LLC currently has a rating of Buy on the shares. A number of other analysts have …